MPM BioImpact’s Lite Strategy Inc LITS Stock Holding History

MPM BioImpact’s Portfolio LITS Stock Details LITS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-617,549	Closed	-$33M	–	38
2021 Q4	$33M	Buy	+617,549	New	+$34.4M	6.01%	4

Other funds holding LITS

NMC

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DCM

DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

MPM BioImpact's LITS Position: Q1 2022 in Review

MPM BioImpact sold out of Lite Strategy Inc (LITS) in Q1 2022, closing a stake of 617,549 shares — an estimated $33M sold.

MPM BioImpact first reported a position in LITS in Q4 2021 and held it in 1 quarter. The position peaked at $33M in Q4 2021. 92 funds tracked by Wall St. Rank hold LITS as of Q1 2022.

MPM BioImpact reported no remaining Lite Strategy Inc position as of Q1 2022 after selling out during the quarter.
MPM BioImpact sold 617,549 Lite Strategy Inc shares in Q1 2022, an estimated $33M.
MPM BioImpact first reported a position in Lite Strategy Inc in Q4 2021 and held it in 1 quarter.
MPM BioImpact's Lite Strategy Inc position peaked at $33M in Q4 2021.
92 funds tracked by Wall St. Rank held Lite Strategy Inc as of Q1 2022.

Based on MPM BioImpact's 13F filing for Q1 2022, filed 13 May 2022.